Endurance Bio

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

Etheros

This company develops small molecule enzyme-mimetic drugs to prevent oxidative and inflammatory injury for patients with neurodegenerative and age-related conditions.

Capacity Bio

This biotechnology company develops small molecule mitophagy inducers and analytical tools for researchers treating neurodegenerative, autoimmune, and muscular disorders.

Endeavor BioMedicines

This clinical-stage biotechnology company develops small-molecule inhibitors and therapies for patients with oncology and fibrotic lung diseases.

Vandria

This biopharmaceutical company develops small molecule mitophagy inducers to treat patients with age-related and chronic diseases, specifically targeting neurodegenerative and muscle disorders.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.

Cellergy Therapeutics

This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.

MitoRx Therapeutics

MitoRx Therapeutics develops small-molecule therapies restoring mitochondrial health to treat patients with high-risk obesity and degenerative diseases.